Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pieris Pharmaceuticals Inc
(NQ:
PIRS
)
16.18
UNCHANGED
Streaming Delayed Price
Updated: 9:54 AM EDT, Oct 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pieris Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 16, 2023
Via
Benzinga
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 18, 2023
Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring.
Via
Benzinga
Why Pieris Pharmaceuticals Shares Shooting Higher Today?
July 18, 2023
Pieris Pharmaceuticals Inc (NASDAQ: PIRS) shares are trading higher after the company
Via
Benzinga
Pieris Pharmaceuticals: Q1 Earnings Insights
May 10, 2023
Via
Benzinga
Recap: Pieris Pharmaceuticals Q1 Earnings
May 10, 2023
Via
Benzinga
Pieris Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Updates
May 10, 2023
Via
ACCESSWIRE
Preview: Pieris Pharmaceuticals's Earnings
May 09, 2023
Via
Benzinga
Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring
July 18, 2023
Via
ACCESSWIRE
3 Doomed Biotech Stocks Destined for Disaster
July 17, 2023
Doomed biotech stocks are a major part of the natural cycle within the sector that results in a lot of failures.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
June 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 23, 2023
Via
Benzinga
Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 23, 2023
Gainers Kidpik Corp. (NASDAQ: PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie 'World's Best'.
Via
Benzinga
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 26, 2023
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular...
Via
Benzinga
Why Are Pieris Pharmaceuticals Shares Tanking Today
June 21, 2023
Pieris Pharmaceuticals Inc (NASDAQ: PIRS) announced that partner AstraZeneca plc (NASDAQ: AZN) decided to discontinue and cease dosing in the ongoing clinical studies of elarekibep, an inhaled IL-4...
Via
Benzinga
Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase 2a Trial of Elarekibep (PRS-060/AZD1402) Due to New Non-Clinical Safety Findings From 13-week Toxicology Study
June 21, 2023
Via
ACCESSWIRE
Pieris Pharmaceuticals Reports Full-Year 2022 Financial Results and Business Updates
March 29, 2023
Via
ACCESSWIRE
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 22, 2023
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private...
Via
Benzinga
Pieris Pharmaceuticals to Present at Jefferies 2023 Healthcare Conference
June 02, 2023
Via
ACCESSWIRE
Pieris Pharmaceuticals Announces Presentation of Encouraging Preclinical Data for PRS-400 at ATS 2023 International Conference
May 22, 2023
Via
ACCESSWIRE
Pieris Pharmaceuticals Announces Presentation of Promising Preclinical Data for PRS-220 at ATS 2023 International Conference
May 21, 2023
Via
ACCESSWIRE
Pieris Pharmaceuticals Announces Successful Completion of Safety Review for 10 mg Dose of Phase 2a Trial of Elarekibep (PRS-060/AZD1402)
May 04, 2023
Via
ACCESSWIRE
Pieris Pharmaceuticals to Host First Quarter 2023 Investor Call and Provide Corporate Update on May 10, 2023
May 02, 2023
Via
ACCESSWIRE
Pieris Pharmaceuticals Announces Presentation of Positive Clinical Data for Cinrebafusp Alpa (PRS-343) At 2023 AACR Annual Meeting
April 17, 2023
Via
ACCESSWIRE
Pieris Pharma Pushes Elarekibep Data Readout, Investors React Negatively
March 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 29, 2023
Via
Benzinga
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 29, 2023
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 29, 2023
Via
Benzinga
Pieris Pharmaceuticals to Host Year End 2022 Investor Call and Provide Corporate Update on March 29, 2023
March 24, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
March 17, 2023
Via
Benzinga
Pieris Pharmaceuticals Announces $5 Million Milestone from Seagen for Initiation of Phase 1 Trial of CD228 x 4-1BB Bispecific Molecule (Mabcalin SGN-BB228 (PRS-346)
January 10, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.